Allen Mooney & Barnes Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Allen Mooney & Barnes Investment Advisors's GILD Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $109K and leaving 15,709 shares worth $1.98M. The position accounts for 0.3% of the portfolio, ranked #54.
Allen Mooney & Barnes Investment Advisors first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.3M in Q1 2026. 1,341 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors held 15,709 shares of Gilead Sciences worth $1.98M as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors sold 825 Gilead Sciences shares in Q2 2026, an estimated $109K.
- Gilead Sciences made up 0.3% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #54 holding.
- Allen Mooney & Barnes Investment Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
- Allen Mooney & Barnes Investment Advisors's Gilead Sciences position peaked at $2.3M in Q1 2026.
- 1,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.